Nicolas Veziris
Veziris, Nicolas, 1971-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 201999747 (Personal)
Permalink: http://viaf.org/viaf/201999747
Preferred Forms
-
100 0 _
‡a
Nicolas Veziris
-
100 1 _
‡a
Veziris, Nicolas
‡d
1971-...
-
100 1 _
‡a
Veziris, Nicolas,
‡d
1971-....
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Amélioration de la prise en charge de la tuberculose en réduisant la durée du traitement. |
|
| Analysis of recovery techniques for non-tuberculous mycobacteria in soil. |
|
| Bedaquiline plus delamanid for XDR tuberculosis. |
|
| Cavitary pulmonary disease in a patient treated with natalizumab |
|
| Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (-15C→T). |
|
| Clonal relationship and differentiation among Mycobacterium abscessus isolates as determined using the semiautomated repetitive extragenic palindromic sequence PCR-based DiversiLab system |
|
| Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients |
|
| Comparison of methods available for the identification of Mycobacterium chimaera. |
|
| Daptomycin is not active against rapidly growing mycobacteria |
|
| Description clinico-bactériologique des infections à mycobacterium simiae |
|
| Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions |
|
| Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, 2004. |
|
| Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones |
|
| Good interpretation of the results of a diagnostic test |
|
| Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris |
|
| Improving TB management and control through innovative shorter anti-tuberculosis regimens |
|
| In vitro activities of β-lactams against Mycobacterium abscessus and search of the β-lactams targets. |
|
| In vivo evaluation of the efficacy of moxifloxacin for the treatment of ofloxacin-resistant tuberculosis. |
|
| In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS [Correspondence] |
|
| Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts |
|
| [Managing multidrug-resistant tuberculosis] |
|
| Mesure et comparaison de l'émergence spontanée de mutants résistants au delamanide chez différentes lignées phylogéniques de mycobacterium tuberculosis |
|
| [Modern diagnosis of tuberculosis]. |
|
| Mycobacterial infection of breast prosthesis--a conservative treatment: a case report |
|
| [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient] |
|
| Novel targets and new therapeutic regimens for the treatment of M. abscessus infections. |
|
| The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation |
|
| Performance of Quantiferon(®) for the diagnosis TB. |
|
| Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance |
|
| Poor performance of rapid molecular tests to define eligibility for the shortcourse MDR-TB regimen |
|
| [R207910 |
|
| Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors. |
|
| Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry |
|
| Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. |
|
| Résistance de Mycobacterium tuberculosis aux fluoroquinolones : histoire naturelle et diagnostic de la résistance |
|
| Resistance of M. leprae to quinolones: a question of relativity? |
|
| Resistance to antituberculous drugs |
|
| Retrospective review of Pneumocystis jirovecii pneumonia in a French intensive care unit (1994–2000) |
|
| Revue de la littérature sur les caractéristiques du complexe Mycobacterium terrae |
|
| Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis. |
|
| Should single antibiotic therapy be avoided for nontuberculous mycobacteria? |
|
| Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare |
|
| Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial Infections |
|
| Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar. |
|
| Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice |
|
| Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis |
|
| Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients. |
|
| A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. |
|
| Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis |
|
| Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond |
|
| Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient |
|
| Traitement de la tuberculose dans le modèle murin : apport des nouveaux antibiotiques |
|
| Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases |
|
| Treatment of tuberculoses in the murine model : contribution of new antibiotics. |
|
| La tuberculose maladie - parcours de soins ambulatoires : étude descriptive monocentrique de 160 cas |
|
| Unbiased estimation of mutation rates under fluctuating final counts |
|
| Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections |
|
| Voluminous pseudotumor due to Mycobacterium malmoense |
|
| [What attitude to adopt before the sequellae of tuberculosis are evident on chest x-ray? Risk of progression and role of chemoprophylaxis before the images of inactive tuberculosis depending on prior treatment and course] |
|
| XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions. |
|
